Monolinkx Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Monolinkx General Information
Description
Operator of a wellness supplement company intended to promote natural relaxation, focus and mental clarity through safe, science-backed ingredients. The company offers a dietary supplement formulated with purified Muscimol from Amanita Muscaria mushrooms, enabling customers to achieve calm, restful sleep and improved focus without the effort of traditional meditation practices.
Contact Information
Website
www.present-perfect.comCorporate Office
- 4967 Newport Avenue
- Suite 12, Number 468
- San Diego, CA 92107
- United States
Corporate Office
- 4967 Newport Avenue
- Suite 12, Number 468
- San Diego, CA 92107
- United States
Monolinkx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Generating Revenue |
Monolinkx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| v7 (Portugal) | Venture Capital | Minority |
Monolinkx FAQs
-
When was Monolinkx founded?
Monolinkx was founded in 2024.
-
Where is Monolinkx headquartered?
Monolinkx is headquartered in San Diego, CA.
-
What industry is Monolinkx in?
Monolinkx’s primary industry is Pharmaceuticals.
-
Is Monolinkx a private or public company?
Monolinkx is a Private company.
-
What is Monolinkx’s current revenue?
The current revenue for Monolinkx is .
-
Who are Monolinkx’s investors?
v7 (Portugal) has invested in Monolinkx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process